Brind.

Stock market activity on July 9, 2026, saw mixed results for companies including AstraZeneca, with some rallying and others facing losses due to factors like drug trial failures.

1 report, 1 independent Updated Jul 9

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

AstraZeneca BAE Systems Anglo American plc

Keep exploring

The entities involved

AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52
BAE Systems
defense, security and aerospace company
- Leonardo and BAE Systems were involved in an airshow where they exhibited weapons used in Israeli conflicts, amidst ongoing scrutiny regarding their products' use in the Gaza Strip.Sat 14:37
- Routine Eurofighter Typhoon training flights are conducted over the Lancashire region.Fri 18:32
Anglo American plc
British multinational mining company
- Analyst firms provided ratings and price targets for Anglo American plc.Sat 01:34

Related events

AstraZeneca is facing market pressure following a clinical trial failure, leading to a decline in its stock value.Jul 9

Coverage

Newest first; wire copies grouped

Jul 9finanznachrichten.de